SURG
Get informed when a big investor buys or sells
+ FollowUndervalued by 1791.7% based on the discounted cash flow analysis.
| Market cap | $4.58 Million |
|---|---|
| Enterprise Value | $17.67 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.8 |
| Beta | 0.27 |
| Outstanding Shares | 23,703,775 |
| P/E Ratio | -0.11 |
|---|---|
| PEG | -0.2 |
| Price to Sales | 0.11 |
| Price to Book Ratio | -0.11 |
| Enterprise Value to Revenue | 0.28 |
| Enterprise Value to EBIT | -0.47 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.88 |
| Debt to Equity | -0.65 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 9.30%▼ 0.97% |
|---|---|
| Total Invested | $1.67M▼ 51.58% |
| Investors Holding | 33▲ 2.00% |
No data